BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 27, 2013
View Archived Issues
Combinatorial strategies to enhance antitumor efficacy of monoclonal antibodies
Read More
Functional polymorphism associated with a predisposition towards allergic asthma reported
Read More
Serum miRNAs as markers of early gastric cancer risk
Read More
Bayer begins new collaboration with Seattle Genetics
Read More
RegeneRx reports results from phase II RGN-137 trial in epidermolysis bullosa
Read More
Myriad Genetics to conduct BRCA testing for Tesaro's niraparib studies
Read More
Boston College patents new PDE11A inhibitors
Read More
CytRx reaches target enrollment in phase IIb aldoxorubicin trial
Read More
Discovery of ROR-gamma inverse agonists for the treatment of Th17-mediated autoimmune diseases
Read More
Prima BioMed to begin three phase II trials of CVac
Read More
Cytokinetics and Astellas form skeletal muscle activator collaboration
Read More
Nanobiotix to develop NBTX-IV together with the NCI
Read More
Preliminary results from phase II trial of DN24-02 in urothelial cancer
Read More
Mesoblast receives approval for trial of mesenchymal precursor cells
Read More
NICE recommends dapagliflozin in certain patients with type 2 diabetes
Read More
Zealand Pharma presents ZP-GA-1, a new glucagon analogue
Read More
Findings link FOXJ1 gene with Barrett's esophagus
Read More
Celgene presents new protein kinase inhibitors
Read More
Boehringer Ingelheim designs novel mGlu5 receptor modulators
Read More
Chiesi Farmaceutici divulges novel MAPK 14 inhibitors
Read More
QRxPharma provides update on MoxDuo NDA review
Read More
Verastem begins phase I trial of VS-4718 in advanced cancer
Read More
Phase I study of MORAb-066 commences
Read More
Vivus obtains European approval for avanafil
Read More
FDA grants fast track designation to Genervon's GM-604 in ALS
Read More